HAVCR2 and osteosarcoma: Nevertheless, TIM-3 was found to be expressed on NK cells, and anti-TIM-3 antibody in combination with a superagonist of IL-15 (ALT-803) enhanced NK cell cytotoxicity against osteosarcoma cells ex vivo (42).